Sort
82,697 grants matching “vaccine development”
Mechanisms of repeated control of acute hepatitis C infection in humans
$791,478Andrea L Cox · Johns Hopkins University · U19 · FY2016 · AI
Targeting HIV-specific T cell differentiation programs to enhance post-treatment control of HIV
$791,450Rachel Lena Rutishauser · University Of California, San Francisco · R01 · FY2022 · AI
Correlates of protective immunity to HCV and rational vaccine design: Project 2
$791,335Arash Grakoui · Emory University · U19 · FY2023 · AI
MHC Variation in Host Response to SARS-CoV2 and COVID-19 Outcomes
$791,237Jill Allison Hollenbach · University Of California, San Francisco · R01 · FY2022 · AI
Oral transmission of KSHV using rhesus macaque rhadinovirus model
$791,132Scott W Wong · Oregon Health & Science University · R01 · FY2022 · CA
Oral transmission of KSHV using rhesus macaque rhadinovirus model
$791,132Scott W Wong · Oregon Health & Science University · R01 · FY2024 · CA
Oral transmission of KSHV using rhesus macaque rhadinovirus model
$791,132Scott W Wong · Oregon Health & Science University · R01 · FY2023 · CA
Development of nonhuman primate reference transcriptome resources
$791,119Michael G Katze · University Of Washington · R24 · FY2011 · RR
Influence of viral and immune interventions on early events following oral SIV infection
$791,082Donald L Sodora · Seattle Children'S Hospital · R01 · FY2024 · DE
NIDA Clinical Trials Network: Greater New York Node
$791,029John P Rotrosen · New York University School Of Medicine · UG1 · FY2017 · DA
Leveraging Community-Academic Partnerships and Social Networks to Disseminate Vaccine-Related Information and Increase Vaccine Uptake Among Black Individuals with Rheumatic Diseases
$791,024Rosalind Ramsey-Goldman · Northwestern University At Chicago · R01 · FY2022 · AR
Animal and Laboratory Core
$791,002Todd M Allen · Massachusetts General Hospital · P01 · FY2013 · AI
The yellow fever vaccine saga: Defining the viral and host determinants responsible for success versus failure
$790,963Charles M. Rice · Rockefeller University · R01 · FY2016 · AI
Role of the microenvironment in regulating early stages of thymic involution and central tolerance
$790,921Lauren Ilyse Richie Ehrlich · University Of Arizona · P01 · FY2023 · AG
ZIMBABWE--COMMUNITY INTERVENTION TO REDUCE HIV/STD RISK
$790,918Battelle Centers/Pub Hlth Res &Evaluatn · U10 · FY2000 · MH
Genomic and Transcriptomic Analysis of Invasive Fungal Pathogens
$790,785Vincent Michael Bruno · University Of Maryland Baltimore · U19 · FY2023 · AI
Immune engineering of optimized sequential immunization strategies for HIV vaccines
$790,753Darrell J Irvine · Massachusetts Institute Of Technology · R61 · FY2021 · AI
Rationally designed platform for enhanced glycoconjugate vaccines
$790,737Dennis L. Kasper · Harvard Medical School · U19 · FY2014 · AI
In vivo transformation of chimeric antigen receptor B cells for a functional cure of HIV
$790,719Michael R. Farzan · Boston Children'S Hospital · R01 · FY2023 · AI
Population genotyping of the germline immunoglobulin repertoire in AIDS-designated rhesus macaque breeding colonies
$790,624Steven Edward Bosinger · Emory University · R24 · FY2021 · AI
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: Quality Assurance/ Quality Control (QA/QC)
$790,559Ranajit Pal · Advanced Bioscience Laboratories, Inc. · N01 · FY2018 · AI
Task A68: Refinement of small animal model potency assays for Filovirus challenge material
$790,533Alan D.t. Barrett · University Of Texas Med Br Galveston · N02 · FY2014 · AI
TB Vaccine Development in Nonhuman Primate Model
$790,437John L Vandeberg · Texas Biomedical Research Institute · R01 · FY2008 · AI
Treating flaviviruses with mRNA-encoded Cas13
$790,410Philip J Santangelo · Emory University · R01 · FY2024 · AI
Gut complement system: Induction and protection against enteric infection
$790,356Dennis L. Kasper · Harvard Medical School · R01 · FY2025 · AI